Study Finds No Causal Link Between ADHD Medication and Psychosis
New research shows that stimulant medications for ADHD do not cause psychosis in children. The study highlights that previous links were confounded by shared risk factors, reaffirming the safety of these treatments.
Recent research indicates that stimulant medications used for treating Attention Deficit/Hyperactivity Disorder (ADHD) do not increase the risk of psychotic episodes in children. The comprehensive study analyzed the health records of nearly 8,400 children involved in an adolescent brain development project in the United States, recruited between 2016 and 2018. Of these children, just under 6% had been prescribed stimulant medications.
Initial results suggested that children on stimulants had a 46% increased risk of experiencing psychosis. However, further analysis revealed a bidirectional association: children who experienced psychotic episodes were also more likely to be prescribed stimulants later. When researchers adjusted for this reciprocal relationship, they found no significant evidence linking the use of ADHD medications to the development of psychosis.
The research, published in the journal a Pediatrics, led by Dr. Ian Kelleher from the University of Edinburgh, points out that earlier perceived links may have been confounded by shared risk factors. Children with more severe ADHD symptoms and additional mental health issues are both more likely to be prescribed stimulants and to experience psychotic symptoms. Therefore, the study concludes that stimulant medications are not causally related to psychosis, and the observed associations are likely due to underlying shared factors.
These findings reassure that ADHD stimulant treatments remain safe concerning psychotic risks, emphasizing the importance of considering the broader mental health context when evaluating these medications.
[Source: https://medicalxpress.com/news/2025-05-link-adhd-meds-psychosis.html]
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Increased Post-Kidney Transplant Risks Associated with BMI-BSA Obesity
Obesity defined by combined BMI and BSA metrics increases the risk of adverse outcomes after kidney transplantation, highlighting the need for accurate assessment methods for better patient management.
SGLT2 Inhibitors Show Safety and Efficacy for Kidney Preservation After Heart Attack
New research shows that SGLT2 inhibitors like empagliflozin are safe and effective for preserving kidney function and reducing heart failure risk in patients after a heart attack, expanding their potential use in post-cardiac event treatment.
Understanding Resistance and Adaptation in Older Home Care Clients’ Agency
A recent study emphasizes the importance of recognizing and supporting the evolving agency of older adults in home care, highlighting resistance, adaptation, and reliance on informal support networks to maintain independence.
How CAR-T Cell Therapy Is Transforming Cancer Treatment
Discover how CAR-T cell therapy is transforming cancer treatment by harnessing genetically engineered immune cells to target and destroy tumors with unprecedented precision and strength.